Apellis Pharmaceuticals
APLS
APLS
95 hedge funds and large institutions have $423M invested in Apellis Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 11 closing their positions.
Holders
95
Holders Change
+16
Holders Change %
+20.25%
% of All Funds
2.12%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
27
Increased
33
Reduced
25
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VP
1
venBio Partners
San Francisco,
California
|
$23.6M |
| 2 |
2
BlackRock
New York
|
$49.2M |
| 3 |
FT
3
Fiduciary Trust
Boston,
Massachusetts
|
$9.31M |
| 4 |
CAM
4
Cormorant Asset Management
Boston,
Massachusetts
|
$59.4M |
| 5 |
O
5
OrbiMed
New York
|
$4.31M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DTL
101
Dynamic Technology Lab
Singapore
| – | – | -25,164 | Closed |
|
|
ARTA
102
A.R.T. Advisors
New York
| – | – | -23,446 | Closed |
|
|
BCM
103
BlueCrest Capital Management
St Helier,
Jersey
| – | – | -12,600 | Closed |
|
|
QT
104
Quantbot Technologies
New York
| – | – | -6,269 | Closed |
|
|
TRCT
105
Tower Research Capital (TRC)
New York
| – | – | -2,704 | Closed |
|
106
Pacer Advisors
Malvern,
Pennsylvania
| – | – | -2,602 | Closed |
|
|
CFGS
107
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|